-+ 0.00%
-+ 0.00%
-+ 0.00%

Baropharm CEO Kim Seul Ki, Related Parties Disclose 39.80% of Voting Rights

PUBT·11/17/2026 06:00:24
Listen to the news
Baropharm CEO Kim Seul Ki, Related Parties Disclose 39.80% of Voting Rights
  • Kim Seul Ki and related parties disclosed a 40.79% holding in Baropharm as of Nov. 17, 2026, covering 4,962,745 shares and rights.
  • Voting rights totaled 4,762,555 shares, representing 39.8%.
  • The initial disclosure followed the Nov. 11 KOSDAQ listing, with holdings intended to influence management.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baropharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261117000105), on November 17, 2026, and is solely responsible for the information contained therein.